Tech Company Financing Transactions
Abingworth Funding Round
Abingworth, based in London, secured $356 million in investment from private investors.
Transaction Overview
Company Name
Announced On
10/30/2023
Transaction Type
Venture Equity
Amount
$356,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Abingworth is a life sciences investment firm offering capital and expertise to management teams building companies. Its therapeutic focused investments fall into three categories: seed and early-stage, development stage, and clinical co-development. Since 1973, Abingworth has invested in over 185 life science companies, leading to 49 M&As and 75 IPOs.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
38 Jermyn St.
London, SW1Y 6DN
UK
London, SW1Y 6DN
UK
Phone
Website
Email Address
Overview
Abingworth is an international investment group collaborating with life sciences entrepreneurs to develop products that have a dramatic impact on health.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Stephen Bunting
Chief Financial Officer
James Abell
VP - General Counsel
John Heard
Browse more venture capital transactions:
Prev: 10/30/2023: Midwest Games venture capital transaction
Next: 10/30/2023: Skyroot Aerospace venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. All VC database entries reported here are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs